LifeLens

LifeLens Technologies develops an advanced physiological monitoring platform that provides comprehensive, real-time and retrospective health data through a compact wearable device. The FDA-cleared platform monitors multiple signals simultaneously, including ECG, SpO2, heart rate, heart rate variability, skin temperature, respiration rate, activity level, body position, step count, and gait analysis. Designed for both defense and healthcare applications, the device is engineered for wearability and durability in tactical environments where rings and watches are impractical, and has been deployed by the Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense (JPEO-CBRND). The platform delivers secure connectivity and data visualization for diagnostic, disease management, and treatment purposes. Founded in 2014 and headquartered in Warminster, United States, the company has raised approximately $39.7 million at the Series B stage.